Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

SQI Diagnostics Inc V.SQD.H

Healthcare Medical Devices
SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

SQI Diagnostics Inc
Bullboard Posts
User Avatar Image
(3)
•••
Comment by WileyCyteon Aug 17, 2018 8:05am
106 Views
Post# 28476461

RE:RE:Earnings out

RE:RE:Earnings outI am not sure I share your enthusiasm Tom. The company is now spending $10 to make $1 and they have been around for how long? Ive actually been a long SH for 2 yrs now and when I look back at the investor presentation from when I first noticed the company, it's impossible not to acknowledge that they have come up laughably short of all financial projections. Now I have to start and question why. Certainly the revenue generated the past 2 quarters is disturbingly low - $176k and $220k? Which has led to a $5 million loss thru Q3. What are they doing exactly to incur those kinds of losses....paying customers for each kit 'sale'? This guy Morris has to go. Every press release is the same for 4 quartery now..."get ready. ...big revenue coming from recurring kit sales"....and then they announce $176k total revenue, for the entire company, for a full financial quarter. That's a joke. I don't know what these mega millionaires see that I don't. Plenty probably but in terms of sqi my patience has simply run out.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities